Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors

Caffeine citrate is the drug of choice for the pharmacological treatment of apnea of prematurity. Factors such as maturity and genetic variation contribute to the interindividual variability in the clinical response to caffeine therapy in preterm infants, making the optimal dose administered controv...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Jia-Yi, Guo, Hong-Li, He, Xin, Hu, Ya-Hui, Xia, Ying, Cheng, Rui, Ding, Xuan-Sheng, Chen, Feng, Xu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350115/
https://www.ncbi.nlm.nih.gov/pubmed/34381359
http://dx.doi.org/10.3389/fphar.2021.681842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350115/
https://www.ncbi.nlm.nih.gov/pubmed/34381359
http://dx.doi.org/10.3389/fphar.2021.681842

Ejemplares similares